Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. 2014

Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, 2100 København Ø, Denmark.

N-Benzyl substitution of 5-HT2A receptor agonists of the phenethylamine structural class of psychedelics (such as 4-bromo-2,5-dimethoxyphenethylamine, often referred to as 2C-B) confer a significant increase in binding affinity as well as functional activity of the receptor. We have prepared a series of 48 compounds with structural variations in both the phenethylamine and N-benzyl part of the molecule to determine the effects on receptor binding affinity and functional activity at 5-HT2A and 5-HT2C receptors. The compounds generally had high affinity for the 5-HT2A receptor with 8b having the highest affinity at 0.29 nM but with several other compounds also exhibiting subnanomolar binding affinities. The functional activity of the compounds was distributed over a wider range with 1b being the most potent at 0.074 nM. Most of the compounds exhibited low to moderate selectivity (1- to 40-fold) for the 5-HT2A receptor in the binding assays, although one compound 6b showed an impressive 100-fold selectivity for the 5-HT2A receptor. In the functional assay, selectivity was generally higher with 1b being more than 400-fold selective for the 5-HT2A receptor.

UI MeSH Term Description Entries
D007295 Inositol Phosphates Phosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID. Inositol Phosphate,Phosphate, Inositol,Phosphates, Inositol
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D044402 Receptor, Serotonin, 5-HT2A A serotonin receptor subtype found widely distributed in peripheral tissues where it mediates the contractile responses of variety of tissues that contain SMOOTH MUSCLE. Selective 5-HT2A receptor antagonists include KETANSERIN. The 5-HT2A subtype is also located in BASAL GANGLIA and CEREBRAL CORTEX of the BRAIN where it mediates the effects of HALLUCINOGENS such as LSD. Serotonin 2A Receptor,5-HT(2A) Receptor,5-HT2A Receptor,Receptor, Serotonin 2A,Serotonin 2A Receptors,5 HT2A Receptor,Receptor, 5-HT2A,Receptors, Serotonin 2A
D044405 Receptor, Serotonin, 5-HT2C A serotonin receptor subtype found primarily in the CENTRAL NERVOUS SYSTEM and the CHOROID PLEXUS. This receptor subtype is believed to mediate the anorectic action of SEROTONIN, while selective antagonists of the 5-HT2C receptor appear to induce ANXIETY. Several isoforms of this receptor subtype exist, due to adenine deaminase editing of the receptor mRNA. Serotonin 2C Receptor,5-HT(2C) Receptor,5-HT2C Receptor,5-Hydroxytryptamine Type 2C Receptor,5-Hydroxytryptamine Type 2C Receptors,Receptor, 5-Hydroxytryptamine Type 2C,5 HT2C Receptor,5 Hydroxytryptamine Type 2C Receptor,5 Hydroxytryptamine Type 2C Receptors,Receptor, 5 Hydroxytryptamine Type 2C,Receptor, 5-HT2C,Receptor, Serotonin 2C
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell

Related Publications

Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
July 2015, Bioorganic & medicinal chemistry,
Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
February 2020, ACS omega,
Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
November 2016, Bioorganic & medicinal chemistry,
Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
May 2024, Journal of medicinal chemistry,
Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
January 2010, Bioorganic & medicinal chemistry,
Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
March 2018, Molecules (Basel, Switzerland),
Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
April 2015, Rapid communications in mass spectrometry : RCM,
Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
March 2008, Bioorganic & medicinal chemistry,
Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
December 2009, Bioorganic & medicinal chemistry letters,
Martin Hansen, and Karina Phonekeo, and James S Paine, and Sebastian Leth-Petersen, and Mikael Begtrup, and Hans Bräuner-Osborne, and Jesper L Kristensen
October 2002, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!